Alnylam Pharmaceuticals
ALNY
#443
Rank
โ‚น4.688 T
Marketcap
โ‚น35,492
Share price
1.00%
Change (1 day)
75.16%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company